PRELUDE THERAPEUTICS INC Proceeds from Common Stock Issued
PRELUDE THERAPEUTICS INC (PRLD) reported Proceeds from Common Stock Issued of $161.42 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-03-15
- PRELUDE THERAPEUTICS INC proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- PRELUDE THERAPEUTICS INC proceeds from issuance of common stock for the quarter ending 2021-09-30 was $0.00.
- PRELUDE THERAPEUTICS INC proceeds from issuance of common stock for the quarter ending 2021-06-30 was $0.00.
- PRELUDE THERAPEUTICS INC proceeds from issuance of common stock for the quarter ending 2021-03-31 was $161.42M.
- PRELUDE THERAPEUTICS INC proceeds from issuance of common stock for fiscal 2021 was $161.42M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $161.42M 10-K · filed 2023-03-15 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $161.42M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $161.42M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $161.42M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |